Kolexia
Boisdron Michele Pharmacien
Boisdron Michele
Pharmacien
Ico - Site Paul Papin
Angers, France
59 Activités
428 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Déficit en dihydropyrimidine déshydrogénase Tumeurs colorectales Adénocarcinome Pleurésie COVID-19 Tumeurs du côlon Tumeurs du rectum Tumeurs de l'appareil digestif Douleur cancéreuse

Collaborateurs

Voir plus
Gamelin Erick
Gamelin Erick
Ico - Site Paul Papin, Angers, France
Capitain Olivier
Capitain Olivier
Ico - Site Paul Papin, Angers, France
Metges Jean-Philippe
Metges Jean-Philippe
Hôpital Morvan, Brest, France
Raoul Jean-Luc
Raoul Jean-Luc
Institut de cancérologie de l'Ouest, Saint-Herblain, France

Industries

Voir plus
Merck-Serono
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19).
Cancers   11 novembre 2022
COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19).
Clinical Medicine Insights. Oncology   18 avril 2022
425P Cetuximab could be administered once every two weeks instead of once weekly
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study.
Cancers   06 juillet 2021
UFT RT Phase 3: Trial UFT/RT Randomized Multicenter Phase III Randomized Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma
Essai Clinique (Merck & Co.)   23 mars 2020
FUSAFE individual patient data meta-analysis (MA) to assess the performance of dihydropyrimidine dehydrogenase (DPD) gene polymorphisms for predicting grade 4-5 fluoropyrimidine (FP) toxicity
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.
Case reports in oncology   05 juin 2019
Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal).
2019 ASCO Annual Meeting I   26 mai 2019
Screening patients for fluoropyrimidine-related toxicity risk.
2019 ASCO Annual Meeting I   26 mai 2019
Primum non nocere: Screening patients for fluoropyrimidine-related toxicity risk: The most effective method
ESMO 20th World Congress on Gastrointestinal Cancer 20–23 June 2018, Barcelona, Spain   01 juin 2018